NEW YORK, Nov. 7, 2023 /PRNewswire/ — The epigenetics market size is expected to grow by USD 1.15 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 14.06% during the forecast period, according to Technavio Research. The market is segmented by application (oncology and non-oncology), product (reagents, kits, and others), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). North America accounts for 40% of the growth of the global market during the forecast period. Some of the main factors which are significantly contributing to the growth of the market include the rising incidence of chronic diseases, increasing healthcare expenditure, and the presence of key companies. In addition, there is an increase in the number of clinical trials in the region, which is positively impacting the market growth. Hence, such factors drive the market growth during the forecast period. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read PDF Sample Report
Technavio has announced its latest market research report titled Global Epigenetics Market 2023-2027
Company Profile:
Abcam plc, Active Motif Inc., Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio Techne Corp., BioVision Inc., CellCentric Ltd., Enzo Biochem Inc., EpiGentek Group Inc., F. Hoffmann La Roche Ltd., Hologic Inc., Illumina Inc., Merck KGaA, New England Biolabs Inc., Pacific Biosciences of California Inc., Perkin Elmer Inc., Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., and Zymo Research Corp
Abcam plc: The company offers epigenetics research which provides study focused on changes in DNA that do not involve alterations to the underlying sequence rather than change in organisms.
• To gain access to more vendor profiles available with Technavio, buy the report!
Epigenetics Market: Segmentation Analysis
The market share growth by the oncology segment is significant during the forecast period. The growing prevalence of cancer signficantly fuels the adoption of epigenetics. Cancer is caused by various factors, such as genetics, lifestyle choices, and exposure to certain environmental factors. In addition, epigenetics solutions enable the identification of diseases including cancer. Hence, such factors are fuelling the growth of this segment which in turn will drive the market growth during the forecast period.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report
“Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021”- Technavio
Epigenetics Market: Driver & Trend:
Drivers
Rising epigenetic applications in non-oncology diseases drive the marekt growth. There is growing traction regarding the significance of epigenetics in non-oncology diseases. Epigenetics mainly includes heritable gene expression changes without altering the DNA sequence, fuelled by environmental factors such as nutrition, stress, toxins, and infections. The identification of epigenetics’ diagnostic potential has resulted in the development of epigenetic-based therapies, targeting enzymes like HDACs and DNMTs. Hence, such factors are positively impacting the marekt which in turn drives the marekt growth during the forecast period.
Increasing prevalence of CVDs
Increase in strategic collaboration and M and A
Trends
Technological advances in life sciences industry is a primary trend in the market. The life sciences industry is undergoing technological advancements fuelled by the increasing prevalence of chronic diseases worldwide and the rising demand for personalized medicine. Hence, such factors are positively impacting the marekt which in turn will drive the marekt growth during the forecast period. Identify key trends, drivers, and challenges in the market. Download to gain access to this information.
Related Reports:
The automated microscopy market size is estimated to grow by USD 1,373.9 million at a CAGR of 9.11% between 2022 and 2027.
The organ preservation market size is estimated to grow by USD 106.96 million at a CAGR of 6.91% between 2022 and 2027.
What are the key data covered in this epigenetics market report?
CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the epigenetics market between 2022 and 2027.
ToC:
Executive Summary
Market Landscape
Market Sizing
Historic Market Sizes
Five Forces Analysis
Market Segmentation by Application
Market Segmentation by Product
Market Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio